Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1996 May;74(3):F191–F194. doi: 10.1136/fn.74.3.f191

Screening for tyrosinaemia type I.

A C Hutchesson 1, S K Hall 1, M A Preece 1, A Green 1
PMCID: PMC2528336  PMID: 8777683

Abstract

AIMS: To assess the incidence of tyrosinaemia type I in the West Midlands Region, and the value of current neonatal screening programmes for phenylketonuria (PKU) for its detection. METHODS: Retrospective study of results from the PKU neonatal screening programmes in Birmingham (using plasma amino acid chromatography) and in the rest of the West Midlands (using the Guthrie microbiological assay for blood spot phenylalanine) was carried out between January 1985 and March 1994. Patients with tyrosinaemia I born in the region during the same period were identified from a regional database of patients with confirmed inherited metabolic disease. The study was carried out in a specialist children's hospital; the regional centre in the West Midlands for neonatal screening and investigation of inborn errors, and a supraregional centre for liver transplantation and management of paediatric liver disease. RESULTS: Amino acid chromatography showed increased tyrosine in 447 of 145,444 neonates born in Birmingham; this was still increased at 6 weeks of age in six cases. Five had tyrosinaemia I; the sixth had tyrosinaemia type III. Two others in whom amino acid chromatography was considered normal have since presented with tyrosinaemia I. Outside Birmingham, 525,151 children were screened using the Guthrie test. Five have presented clinically with tyrosinaemia I; screening did not contribute to diagnosis in any case. The incidence of tyrosinaemia I was 1 in 20,791 live births within Birmingham and 1 in 105,037 outside. Of the total 12 patients in the West Midlands with tyrosinaemia I, 10 (83%) were of non-oriental Asian ethnicity; the incidence of tyrosinaemia I was 3.7/10(6) head of population in this group and 0.04/10(6) in the rest of the population. CONCLUSIONS: Asians in the West Midlands have a high incidence of tyrosinaemia I. Neonatal PKU screening using amino acid chromatography may contribute to diagnosis and early treatment.

Full text

PDF
F191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. GUTHRIE R., SUSI A. A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. Pediatrics. 1963 Sep;32:338–343. [PubMed] [Google Scholar]
  2. Grenier A., Laberge C. A modified automated fluorometric method for tyrosine determination in blood spotted on paper: a mass screening procedure for tyrosinemia. Clin Chim Acta. 1974 Nov 20;57(1):71–75. doi: 10.1016/0009-8981(74)90179-x. [DOI] [PubMed] [Google Scholar]
  3. Grenier A., Lescault A., Laberge C., Gagné R., Mamer O. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia. Clin Chim Acta. 1982 Aug 4;123(1-2):93–99. doi: 10.1016/0009-8981(82)90117-6. [DOI] [PubMed] [Google Scholar]
  4. Grompe M., St-Louis M., Demers S. I., al-Dhalimy M., Leclerc B., Tanguay R. M. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. N Engl J Med. 1994 Aug 11;331(6):353–357. doi: 10.1056/NEJM199408113310603. [DOI] [PubMed] [Google Scholar]
  5. Holme E., Lindstedt S. Neonatal screen for hereditary tyrosinaemia type I. Lancet. 1992 Oct 3;340(8823):850–850. doi: 10.1016/0140-6736(92)92724-t. [DOI] [PubMed] [Google Scholar]
  6. Kelly D. A. Organ transplantation for inherited metabolic disease. Arch Dis Child. 1994 Sep;71(3):181–183. doi: 10.1136/adc.71.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kvittingen E. A. Tyrosinaemia type I--an update. J Inherit Metab Dis. 1991;14(4):554–562. doi: 10.1007/BF01797926. [DOI] [PubMed] [Google Scholar]
  8. Laberge C., Grenier A., Valet J. P., Morissette J. Fumarylacetoacetase measurement as a mass-screening procedure for hereditary tyrosinemia type I. Am J Hum Genet. 1990 Aug;47(2):325–328. [PMC free article] [PubMed] [Google Scholar]
  9. Larochelle J., Mortezai A., Belanger M., Tremblay M., Claveau J. C., Aubin G. Experience with 37 infants with tyrosinemia. Can Med Assoc J. 1967 Oct 28;97(18):1051–1054. [PMC free article] [PubMed] [Google Scholar]
  10. Lindstedt S., Holme E., Lock E. A., Hjalmarson O., Strandvik B. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet. 1992 Oct 3;340(8823):813–817. doi: 10.1016/0140-6736(92)92685-9. [DOI] [PubMed] [Google Scholar]
  11. Pérez-Cerdá C., Merinero B., Sanz P., Castro M., Gangoiti J., García M. J., Díaz M., Medina E., Ugarte M. Liver transplantation in nine Spanish patients with tyrosinaemia type I. J Inherit Metab Dis. 1995;18(2):119–122. doi: 10.1007/BF00711744. [DOI] [PubMed] [Google Scholar]
  12. SCRIVER C. R., DAVIES E., CULLEN A. M. APPLICATION OF A SIMPLE MICROMETHOD TO THE SCREENING OF PLASMA FOR A VARIETY OF AMINOACIDOPATHIES. Lancet. 1964 Aug 1;2(7353):230–232. doi: 10.1016/s0140-6736(64)90183-7. [DOI] [PubMed] [Google Scholar]
  13. Wijburg F. A., Reitsma W. C., Slooff M. J., van Spronsen F. J., Koetse H. A., Reijngoud D. J., Smit G. P., Berger R., Bijleveld C. M. Liver transplantation in tyrosinaemia type I: the Groningen experience. J Inherit Metab Dis. 1995;18(2):115–118. doi: 10.1007/BF00711743. [DOI] [PubMed] [Google Scholar]
  14. de Almeida I. T., Leandro P. P., Silva M. F., Silveira C., da Silva A., de Sousa J. S., Duran M. Tyrosinaemia type I with normal levels of plasma tyrosine. J Inherit Metab Dis. 1990;13(3):305–307. doi: 10.1007/BF01799381. [DOI] [PubMed] [Google Scholar]
  15. van Spronsen F. J., Smit G. P., Wijburg F. A., Thomasse Y., Visser G., Heymans H. S. Tyrosinaemia type I: considerations of treatment strategy and experiences with risk assessment, diet and transplantation. J Inherit Metab Dis. 1995;18(2):111–114. doi: 10.1007/BF00711742. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES